S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
All the trading advice you’ve ever received boils down to this (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
All the trading advice you’ve ever received boils down to this (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
All the trading advice you’ve ever received boils down to this (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
All the trading advice you’ve ever received boils down to this (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
All the trading advice you’ve ever received boils down to this (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
All the trading advice you’ve ever received boils down to this (Ad)
3 must-own China stocks for the Year of the Dragon
Broadcom falls into a buy-the-dip opportunity 

AptarGroup (ATR) Stock Forecast & Price Target

$127.35
+0.86 (+0.68%)
(As of 12/8/2023 ET)
Compare
Today's Range
$125.62
$127.49
50-Day Range
$121.18
$128.57
52-Week Range
$105.78
$133.79
Volume
265,821 shs
Average Volume
259,759 shs
Market Capitalization
$8.38 billion
P/E Ratio
30.25
Dividend Yield
1.29%
Price Target
$140.00

AptarGroup Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 4 Analyst Ratings

Analysts' Consensus Price Target

$140.00
9.93% Upside
High Forecast$152.00
Average Forecast$140.00
Low Forecast$125.00
TypeCurrent Forecast
12/9/22 to 12/9/23
1 Month Ago
11/9/22 to 11/9/23
3 Months Ago
9/10/22 to 9/10/23
1 Year Ago
12/9/21 to 12/9/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$140.00$140.00$130.83$116.83
Predicted Upside9.93% Upside17.04% Upside17.22% Upside14.92% Upside
Get AptarGroup Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ATR and its competitors with MarketBeat's FREE daily newsletter.


ATR Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ATR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

AptarGroup Stock vs. The Competition

TypeAptarGroupMedical CompaniesS&P 500
Consensus Rating Score
2.75
2.68
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside9.93% Upside728.30% Upside3,819.09% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/11/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$140.00 ➝ $152.00+21.30%
7/10/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$152.00 ➝ $149.00+31.40%
5/1/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$130.00 ➝ $134.00+9.57%
5/1/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$115.00 ➝ $125.00+5.48%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:45 AM ET.












ATR Price Target - Frequently Asked Questions

What is AptarGroup's consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for AptarGroup stock is Moderate Buy based on the current 1 hold rating and 3 buy ratings for ATR. The average twelve-month price prediction for AptarGroup is $140.00 with a high price target of $152.00 and a low price target of $125.00. Learn more on ATR's analyst rating history.

Do Wall Street analysts like AptarGroup more than its competitors?

Analysts like AptarGroup more than other Medical companies. The consensus rating score for AptarGroup is 2.75 while the average consensus rating score for medical companies is 2.68. Learn more on how ATR compares to other companies.

Does AptarGroup's stock price have much upside?

According to analysts, AptarGroup's stock has a predicted upside of 17.04% based on their 12-month stock forecasts.

What analysts cover AptarGroup?

AptarGroup has been rated by Wells Fargo & Company in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:ATR) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -